Macrophage inhibitory cytokine-1: possible bridge molecule of inflammation and prostate cancer.
There is emerging evidence that inflammation may lead to prostate cancer development. Although inflammation is an essential response to injury or infection, chronic inflammation is harmful and causes tissue damage. Increasing evidence suggests that inflammation leads to the development of epithelial cancers; however, studies on inflammation-targeted genes that might contribute to the development of cancer are at the beginning stage. Here, we describe macrophage inhibitory cytokine-1, which provides a potential link between inflammation and prostate cancer. Understanding the regulation of macrophage inhibitory cytokine-1 in response to inflammation may have potential for novel therapeutic strategies.
Karan
Dev
D
Veterans Affairs Medical Center, 4801 Linwood Boulevard, Kansas City, MO 64128, USA. dkaran@kumc.edu
Holzbeierlein
Jeffrey
J
Thrasher
J Brantley
JB
D000818:Animals; D055436:Growth Differentiation Factor 15 / Q000276:immunology / Q000378:metabolism*; D006801:Humans; D007249:Inflammation / Q000276:immunology / Q000378:metabolism / Q000473:pathology*; D008297:Male; D011471:Prostatic Neoplasms / Q000276:immunology / Q000473:pathology*
C526140:GDF15 protein, human; D055436:Growth Differentiation Factor 15